From: Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia
Question | n (%) |
---|---|
Total | 29 (100%) |
What should a new treatment mainly improve? | |
Quality of life | 17 (59.2%) |
Less hypoglycemic episodes | 5 (18.2%) |
no response | 7 (22.2%) |
For which trial length could you imagine to take a study medication? | |
two weeks | 2 (9.5%) |
one month | 4 (19.0%) |
three months | 3 (14.3%) |
six months | 6 (28. 5%) |
nine months | 0 (0%) |
one year | 5 (23.8%) |
free text option: one and a half year | 1 (4.7%) |
no response | 6 (28.5%) |